Shares of GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 10,000 shares traded.
GB Sciences Price Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
See Also
- Five stocks we like better than GB Sciences
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- Quiet Period Expirations Explained
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- Stock Market Sectors: What Are They and How Many Are There?
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
